Good...The latest release states that the test could be improved to better show early detection if it was able to be personalized over a period of time.
Bad..The above statement shows that the current test is set at a level that is too high to consistently detect early cancers.
THE CURRENT TEST DOES DETECT CANCER WITH MORE ACCURACY THAN ANYTHING ELSE WE HAVE. IT DOES NOT HAVE TO BE PERSONALIZED TO DETECT CANCER. THE GOOD IS THE TEST. THE BETTER IS THAT THE COLORIZATION NOW MAKES THE TEST EASIER TO USE. IT DOES NOT HAVE TO BE PERSONALIZED TO WORK.
Good..If Abbott is positive in the feasibility study, the milestone should be significant.
Bad..The test ran by itself is not definitive. A high level of RECAF would just indicate that further diagnosis or testing should be done.
THE TEST SHOWS WHETHER CANCER IS PRESENT. BETTER: OTHER TESTS RUN USING RECAF ON TISSUE SAMPLES FROM SPECIFIC AREAS WHERE THE CANCER MAY BE. WE HAVE A USE FOR RECAF AS A GENERAL MARKER AND THEN AS A SPECIFIC MARKER.
My better half only has 3k shares. That is not a huge gamble and I did not suggest that she sell but IMO, owning it right now is like going to Vegas and laying it all on black.
IMO ANYTHING YOUR BETTER HALF DOES WITH MONEY WOULD BE SCRUTINIZED UNDER A MICROSCOPE. TRUST HER. SHE HAS INTUITION WHICH YOU MIGHT LACK. AND IF YOU DID SUGGEST THAT SHE SELL IT, WOULD SHE?
News 
Market Data 
Discover 
AI
